ID   KCP-4
AC   CVCL_M123
DR   Wikidata; Q54899700
RX   PubMed=8200854;
RX   PubMed=22562377;
RX   PubMed=24317338;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
RX   PubMed=22562377; DOI=10.3892/or.2012.1801;
RA   Oiso, Shigeru
RA   Ikeda, Ryuji
RA   Nakamura, Kazuo
RA   Takeda, Yasuo
RA   Akiyama, Shin-ichi
RA   Kariyazono, Hiroko
RT   "Involvement of NF-kappaB activation in the cisplatin resistance of
RT   human epidermoid carcinoma KCP-4 cells.";
RL   Oncol. Rep. 28:27-32(2012).
//
RX   PubMed=8200854; DOI=10.1111/j.1349-7006.1994.tb02376.x; PMCID=PMC5919474;
RA   Fujii, Ryu-ichi
RA   Mutoh, Masato
RA   Niwa, Kiyoshi
RA   Yamada, Kazutaka
RA   Aikou, Takashi
RA   Nakagawa, Masayuki
RA   Kuwano, Michihiko
RA   Akiyama, Shin-ichi
RT   "Active efflux system for cisplatin in cisplatin-resistant human KB
RT   cells.";
RL   Jpn. J. Cancer Res. 85:426-433(1994).
//
RX   PubMed=24317338; DOI=10.3892/or.2013.2896;
RA   Oiso, Shigeru
RA   Takayama, Yui
RA   Nakazaki, Rie
RA   Matsunaga, Naoko
RA   Motooka, Chie
RA   Yamamura, Asuka
RA   Ikeda, Ryuji
RA   Nakamura, Kazuo
RA   Takeda, Yasuo
RA   Kariyazono, Hiroko
RT   "Factors involved in the cisplatin resistance of KCP-4 human epidermoid
RT   carcinoma cells.";
RL   Oncol. Rep. 31:719-726(2014).
//